Immunoprecise Antibodies Ltd
XTSX:IPA

Watchlist Manager
Immunoprecise Antibodies Ltd Logo
Immunoprecise Antibodies Ltd
XTSX:IPA
Watchlist
Price: 6.5 CAD 0.78% Market Closed
Market Cap: 161.4m CAD

Intrinsic Value

IPA price has not been updated for more than 2 months. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the intrinsic value of IPA.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IPA Intrinsic Value
Not Available
Base Case Scenario
Compare IPA to

Fundamental Analysis

Immunoprecise Antibodies Ltd
XTSX:IPA
CA
Life Sciences Tools & Services
Market Cap
161.4m CAD
IPO
Jan 30, 1987
CA
Life Sciences Tools & Services
Market Cap
161.4m CAD
IPO
Jan 30, 1987
Price
CA$
CA$
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about IPA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Immunoprecise Antibodies Ltd

Balance Sheet Decomposition
Immunoprecise Antibodies Ltd

Current Assets 40.6m
Cash & Short-Term Investments 33m
Receivables 3.5m
Other Current Assets 4.1m
Non-Current Assets 15.9m
Long-Term Investments 100k
PP&E 3.6m
Intangibles 4.5m
Other Non-Current Assets 7.7m
Current Liabilities 7.1m
Other Current Liabilities 7.1m
Non-Current Liabilities 1.6m
Long-Term Debt 540k
Other Non-Current Liabilities 1.1m
Efficiency

Free Cash Flow Analysis
Immunoprecise Antibodies Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Immunoprecise Antibodies Ltd

Revenue
19m CAD
Cost of Revenue
-8.6m CAD
Gross Profit
10.5m CAD
Operating Expenses
-25.5m CAD
Operating Income
-15m CAD
Other Expenses
-2.1m CAD
Net Income
-17.1m CAD
Fundamental Scores

IPA Profitability Score
Profitability Due Diligence

Immunoprecise Antibodies Ltd's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
ROIC is Increasing
Declining Gross Margin
21/100
Profitability
Score

Immunoprecise Antibodies Ltd's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

IPA Solvency Score
Solvency Due Diligence

Immunoprecise Antibodies Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Immunoprecise Antibodies Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IPA Price Targets Summary
Immunoprecise Antibodies Ltd

There are no price targets for IPA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for IPA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y